Health Care/Hospital

Australasian College of Pharmacy and MedAdvisor Solutions Launch MedAdvisor software training for the Queensland Community Pharmacy Scope of Practice Pilot

Uplifting pharmacists' role in primary care and positioning pharmacies as  essential care destinations in local communities  CAMBERWELL, Australia, July 25, 2024 /PRNewswire/ -- MedAdvisor Solutions and the Australasian College of Pharmacy today announced the launch of the MedAdvisor software tra...

2024-07-25 05:00 2119

ADVANCION AWARDED ECOVADIS GOLD SUSTAINABILITY RATING FOR SIXTH YEAR

BUFFALO GROVE, Ill., July 24, 2024 /PRNewswire/ -- Advancion Corporation ("Advancion" or "Company"), a leading global producer of specialty ingredients for the life sciences, home and personal care, and other consumer-oriented and industrial markets, today announced it has received the EcoVadis G...

2024-07-24 23:15 1894

AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event

Announcing Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform CAMBRIDGE, Mass., July 24, 2024 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently hosts Insilico Medicine...

2024-07-24 21:00 1456

iHerb Welcomes Martha Stewart Wellness to its Global Assortment

IRVINE, Calif., July 24, 2024 /PRNewswire/ -- iHerb, one of the world's leading e-commerce retailers for vitamins, minerals, supplements, and other health and wellness products, today announced the addition of three innovative new supplement products fromMartha Stewart, Marquee Brands and Project...

2024-07-24 21:00 4368

SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study

SoniVie announces RDN pilot results, radial access FIH and FDA pivotal IDE approval, initiating the global THRIVE study in US,Europe and Israel TEL AVIV, Israel, July 24, 2024 /PRNewswire/ -- SoniVie , which has developed a novel proprietary Therapeutic Intra-Vascular Ultras...

2024-07-24 20:09 1553

SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study

SoniVie announces RDN pilot results, radial access FIH and FDA pivotal IDE approval, initiating the global THRIVE study in US,Europe and Israel TEL AVIV, Israel, July 24, 2024 /PRNewswire/ -- SoniVie , which has developed a novel proprietary Therapeutic Intra-Vascular Ultras...

2024-07-24 19:46 1368

EZRA AND SIMON SINEK BRING PERSONALIZED COACHING TO 1,000 FRONTLINE HEALTHCARE WORKERS

'Gift of Coaching' program will provide free coaching to nurses, residents, paramedics, Advanced Practice Providers, and allied health professionals to help elevate their professional and personal lives NEW YORK, July 24, 2024 /PRNewswire/ -- EZRA, an LHH brand, today launched the Gift of Coachin...

2024-07-24 19:30 1729

deCODE genetics: Variants in the genome affect DNA methylation

REYKJAVIK, Iceland, July 24, 2024 /PRNewswire/ -- A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases as well as other human traits.   ...

2024-07-24 17:00 1719

For the First time in Thailand! Chulalongkorn University Researchers Found a "Glowing Land Snail"

BANGKOK, July 24, 2024 /PRNewswire/ -- Chulalongkorn University researchers have discovered Thailand's first glowing land snail  and the first one in the world in the last 80 years.  Preparations are underway to decode it...

2024-07-24 16:46 2450

Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services

Aragen Life Sciences Ltd. excels in providing end-to-end drug discovery and development solutions, showcasing its innovative approaches and strong commitment to sustainability and customer satisfaction. SAN ANTONIO, July 24, 2024 /PRNewswire/ -- Frost & Sullivan has recognized Aragen Life Scienc...

2024-07-24 12:30 1628

IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis

SHANGHAI, NANJING, China and SAN JOSE, Calif., July 23, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, announced that the investigational new d...

2024-07-24 09:52 1731

SINGAPORE INKS MOU WITH QUANTINUUM, ENABLING ACCESS TO THEIR ADVANCED QUANTUM COMPUTER

SINGAPORE, July 24, 2024 /PRNewswire/ -- Singapore's National Quantum Office (NQO), Agency for Science, Technology and Research (A*STAR),National University of Singapore (NUS), National Supercomputing Centre (NSCC) and Quantinuum signed a Memorandum of Understanding (MoU) today, enabling access t...

2024-07-24 09:00 2579

FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

MELBOURNE, Australia, July 24, 2024  /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces thatthe United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx, a new and proprietary cold ki...

2024-07-24 08:10 1845

Telix Successfully Prices A$650 Million Convertible Bonds

MELBOURNE, Australia, July 24, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX) (Telix, the Company, the Issuer) is pleased to announce that it has successfully pricedA$650 million 2.375 per cent convertible notes due 2029. The convertible notes, also referred to as "convertible bond...

2024-07-24 07:51 1840

ViewMind Applauded by Frost & Sullivan for Revolutionizing Brain Health Assessment and Care with Its Ocular Digital Phenotyping Solution

ViewMind's Ocular Digital Phenotyping solution is a holistic approach to brain and mental health that builds trust through technology, enabling universal, language-free usage for fast and accurate results. SAN ANTONIO, July 23, 2024 /PRNewswire/ -- Frost & Sullivan recently analyzed the brain, m...

2024-07-23 21:00 1806

The most purchased health supplement by foreigners visiting Korea, "JungKwanJang," is now available at Sprouts Farmers Market

CERRITOS, Calif., July 23, 2024 /PRNewswire/ -- Customers can now find Korea's representative health supplement brand "JungKwanJang" at the premium market "Sprouts Farmers Market." JungKwanJang is now available at Sprouts Farmers Market! ...

2024-07-23 19:00 3937

Telix Announces A$600 Million Convertible Bonds Offering

MELBOURNE, Australia, July 23, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX) (Telix, the Company, the Issuer) today launches an offering ofA$600 million of convertible notes due 2029 (the Offering). The convertible notes, also referred to as "convertible bonds" (Convertible Bonds)...

2024-07-23 16:35 1752

SND Introduces Revolutionary Moderated Drinking Treatment Program

TOKYO, July 23, 2024 /PRNewswire/ -- SND Incorporated (Headquarters: Chiyoda-ku, Tokyo; CEO: Takayuki Hiiragi) is proud to announce the launch of its groundbreaking Moderated Drinking Treatment Program for alcohol dependency. This innovative approach offers a compassionate alternative to tradition...

2024-07-23 16:29 1813

Linical Named Best Global CRO by Global Health & Pharma Magazine

OSAKA, Japan, July 23, 2024 /PRNewswire/ -- Linical, a global Contract Research Organization (CRO) for full-service drug development, has been awarded the title ofBest Global CRO 2024 by Global Health & Pharma (GHP) Magazine. The award comes as part of the publication's annual Global Excellence A...

2024-07-23 09:00 2037

DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease

* Receives FDA acceptance on Phase III clinical protocols for parallel pivotal and confirmatory trials * Achieves alignment with FDA on Chemistry, Manufacturing, and Controls (CMC) aspects of Phase III program SALT LAKE CITY, July 23, 2024 /PRNewswire/ --  DiscGenics, Inc., a privately held, l...

2024-07-23 08:00 1650
1 ... 56575859606162 ... 847

Week's Top Stories